Falko Fend

Papers

Total Citations

H-Index

About

Falko Fend is a distinguished researcher in urologic oncology, with a primary focus on improving the accuracy and outcomes of prostate cancer diagnosis. His most notable contribution centers on the advancement of targeted biopsy techniques, particularly through the investigation of robot-assisted transperineal fusion biopsy. In his landmark 2016 study, "First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy," Fend demonstrated the superior precision of this approach in detecting clinically significant cancers while reducing unnecessary sampling. This work, which has garnered 16 citations, has helped refine the standard of care for men requiring repeat biopsies, minimizing false negatives and overtreatment. Fend’s research addresses a critical gap in urology: the challenge of accurately targeting suspicious lesions identified on multiparametric MRI. By validating robotic-assisted platforms, he has contributed to a paradigm shift toward more personalized, less invasive diagnostic strategies. His findings are particularly impactful for patients with prior negative biopsies but persistent clinical suspicion, offering a reliable path to definitive diagnosis. Fend’s work continues to influence clinical guidelines and inspire further innovation in image-guided prostate interventions.